From: Cancer incidence and mortality trends in Australian adolescents and young adults, 1982–2007
Diagnostic Group | n(%) | M:F |
---|---|---|
Leukaemia | 444 (3.6) | 1.4 |
ALL | 120 (1.0) | 1.7 |
AML & CML | 276 (2.3) | 1.2 |
Other | 48 (0.4) | 2.5 |
Lymphoma | 907 (7.4) | 1.3 |
NHL | 472 (3.9) | 1.6 |
HL | 435 (3.5) | 1.0 |
CNS Tumour | 406 (3.3) | 1.3 |
Bone | 183 (1.5) | 1.4 |
Soft Tissue | 323 (2.6) | 1.4 |
Germ Cell | 960 (7.8) | 10.5 |
Gonadal | 875 (7.1) | 24.0 |
Non−gonadal | 85 (0.7) | 1.4 |
Melanoma | 3551 (29.0) | 0.9 |
Carcinoma | 5012 (40.9) | 0.4 |
Thyroid | 640 (5.2) | 0.3 |
Lip & oral cavity | 515 (4.2) | 3.6 |
Gonads | 107 (0.9) | 0.01 |
Lung | 129 (1.1) | 1.1 |
Breast | 1440 (11.8) | na |
Cervix | 782 (6.4) | na |
Colorectum | 500 (4.1) | 1.0 |
Other | 899 (7.3) | 2.2 |
Other | 452 (3.7) | 0.6 |
Total | 12238 | 0.7 |